Minerva Neurosciences, Inc. announced that it has entered into a securities purchase agreement to issue an aggregate of 1,425,000 shares at a price of $10 per share for the gross proceeds of $14.25 million and 575,575 pre-funded warrants at a price of $9.99 per warrant for the gross proceeds of $5.749994 million for the total gross proceeds of $19.999994 million on June 27, 2023. Each warrant has an exercise price of 0.01 per warrant. The transaction is expected to close on or about June 30, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.435 USD | +1.46% | +0.21% | -60.41% |
May. 01 | Minerva Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 27 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.41% | 16.78M | |
-1.20% | 104B | |
+7.24% | 97.47B | |
+5.71% | 22.25B | |
-12.73% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-9.99% | 16.36B | |
+8.53% | 14.39B | |
+39.70% | 12.37B |
- Stock Market
- Equities
- NERV Stock
- News Minerva Neurosciences, Inc.
- Minerva Neurosciences, Inc. announced that it expects to receive $19.999994 million in funding